526299

- Mphasis Limited granted 415,060 Employee Stock Options (ESOPs) under ESOP 2016 at an exercise price of ₹2,371 and 92,400 Restricted Stock Units (RSUs) under RSU Plan 2021 at an exercise price of ₹10 on August 20, 2026.

- Mphasis Limited's ESOP Compensation Committee approved the allotment of 700 Equity Shares on August 20, 2026. - These shares are against the exercise of Restricted Stock Units (RSUs) under the RSU Plan 2021.

- Mphasis Limited received an independently assigned ESG Score of 72.6 (Grade B) for FY 2025-26 from SES ESG Research Private Limited. - The score for FY 2024-25 was 74.5 (Grade B).

- Mphasis Limited to participate in multiple investor/analyst meetings: - Aug 12, 2026: Emkay Confluence 2026 Conference (One-One & Group, Mumbai) - Aug 13, 2026: Equirus Annual India Conference (One-One & Group, Mumbai) - Aug 18, 2026: Motilal Oswal Annual Global Investor Conference, 2026 (One-One & Group, Mumbai)

- Mphasis's overall ESG rating upgraded to 'Crisil ESG 67' from 'Crisil ESG 64'. - Core ESG rating upgraded to 'Crisil Core ESG 73' from 'Crisil Core ESG 69'. - The rating was independently assigned by CRISIL ESG Ratings & Analytics Limited.

- Mphasis awarded Silver Medal in EcoVadis Sustainability Assessment for FY2026. - The company achieved an overall score of 75 out of 100, demonstrating strong performance in sustainability.

- Mphasis allotted 3,606 Equity Shares on July 31, 2026. - Shares were allotted against the exercise of Employee Stock Options (3,400 shares) and Restricted Stock Units (206 shares). - The Mphasis Employees Equity Reward Trust will deduct shares to cover exercise price and taxes, with proceeds used to repay company loans.

- Q1 FY27 revenue grew 2.1% sequentially and 8.3% YoY in constant currency to $471 million. - Net new TCV for Q1 was $461 million, marking the fifth consecutive quarter above $400 million, including three large deals. - Pipeline has grown to an all-time high, 2.8 times its original size, with AI-led deals now forming 70%. - Q2 is positioned to deliver the best sequential constant currency growth in three years. - Maintains FY27 guidance for high single-digit to low double-digit constant currency growth and EBIT margin of 14.75%-15.75%. - Q1 EBIT margin was impacted by ramp-up costs for new deal wins and TAP acquisition, with normalization expected over the year. - Operating cash flow conversion is expected at 80% of net income through FY27. - The Mphasis Tria™ platform shows strong early traction, driving recurring, platform-attached revenue and elevating client conversations to business outcomes.

- The audio recording of the Investor(s)/Analyst(s) call held on July 24, 2026, in connection with the financial results for the quarter ended June 30, 2026, is available on the company's website.

- Mphasis received notices from BSE and NSE for non-compliance with SEBI Regulation 17(1) for quarters ended December 31, 2025, and March 31, 2026, primarily related to Board composition. - Fines of ₹35,400 (inclusive of GST) per exchange were levied for the March 31, 2026, quarter. - The company has filed a waiver application, the outcome of which is awaited. - Failure to resolve could lead to freezing of promoter shares or suspension of trading.

- Consolidated Revenue ₹4,384.05 Cr vs ₹3,732.49 Cr (▲17.5% YoY) - EBITDA ₹795.50 Cr vs ₹702.87 Cr (▲13.2% YoY) - PAT ₹489.51 Cr vs ₹441.70 Cr (▲10.8% YoY) - EBITDA Margin 18.15% vs 18.83% (▼68bps) - Board approved a final dividend of ₹62 per equity share for the year ended March 31, 2026.

- Consolidated Revenue ₹4,384.05Cr vs ₹3,732.49Cr (▲17.5% YoY) - EBITDA ₹795.50Cr vs ₹702.87Cr (▲13.2% YoY) - PAT ₹489.51Cr vs ₹441.70Cr (▲10.8% YoY) - EBITDA Margin 18.14% vs 18.83% (▼69bps)

- Consolidated Revenue ₹43,841 Mn vs ₹37,325 Mn (▲17.5% YoY) - EBITDA ₹7,955 Mn vs ₹7,029 Mn (▲13.2% YoY) - PAT ₹4,895 Mn vs ₹4,417 Mn (▲10.8% YoY) - EBITDA Margin 18.15% vs 18.83% (▼68bps)

- The 35th Annual General Meeting (AGM) was held on July 23, 2026. All resolutions were passed with requisite majority. Resolutions included the adoption of financial statements, declaration of a final dividend of ₹62 per equity share, and re-appointment of directors, including the CEO and Managing Director.

- The 35th Annual General Meeting (AGM) was held on July 23, 2026, through video conferencing. - Shareholders approved the adoption of audited standalone and consolidated financial statements for the year ended March 31, 2026. - A final dividend of ₹62/- per equity share for FY ended March 31, 2026, was declared. - Re-appointments of various directors and Mr. Nitin Rakesh as MD & CEO for 5 years were approved. - Management highlighted strong performance in FY26 with AI-led growth and reaffirmed confidence in the Company's long-term strategy.

- Chairperson's speech at the 35th Annual General Meeting held on July 23, 2026. - Noted complex macro environment and enterprises' hesitation in AI adoption due to rapid change and lack of a clear playbook. - Mphasis is helping clients navigate AI transformation, with New TCV wins growing 68% to USD 2.1 billion in FY26. - 60% of new TCV wins and 69% of the pipeline are AI-led. - Expressed confidence in translating strong pipeline and TCV growth into sustained revenue growth.